You are currently viewing the abstract.View Full Text
Reevaluation of clinical data from the recent failed immunotherapy trials suggests that researchers should continue the quest to cure type 1 diabetes with immune therapies.
Citation: K. C. Herold, J. A. Bluestone, Type 1 Diabetes Immunotherapy: Is the Glass Half Empty or Half Full? Sci. Transl. Med. 3, 95fs1 (2011).
- Copyright © 2011, American Association for the Advancement of Science